Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07856082
PHASE1/PHASE2
Opt-IVF for Personalized Medicine for Normal Responders
Sponsor: Urmila DIwekar
View on ClinicalTrials.gov
Summary
A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.
Official title: The Advanced Decision Support Tool, Opt-IVF for Personalized Medicine for IVF Antagonist and Progesterone-Primed Ovarian Stimulation (PPOS) Protocol for Normal Responders
Key Details
Gender
FEMALE
Age Range
20 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-10-15
Completion Date
2027-04-30
Last Updated
2026-10-02
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Opt-IVF
Opt-IVF predicted dosage for IVF
OTHER
control
Doctor prescribed dosage
Locations (1)
ABC IVF
West Palm Beach, Florida, United States